SE0400501D0 - Antibody purification - Google Patents

Antibody purification

Info

Publication number
SE0400501D0
SE0400501D0 SE0400501A SE0400501A SE0400501D0 SE 0400501 D0 SE0400501 D0 SE 0400501D0 SE 0400501 A SE0400501 A SE 0400501A SE 0400501 A SE0400501 A SE 0400501A SE 0400501 D0 SE0400501 D0 SE 0400501D0
Authority
SE
Sweden
Prior art keywords
cation
aromatic
solution
modal
exchanging group
Prior art date
Application number
SE0400501A
Other languages
English (en)
Inventor
Bo-Lennart Johansson
Hans J Johansson
Anders Ljungloef
Jean-Luc Maloisel
Nicolas Thevenin
Original Assignee
Amersham Biosciences Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amersham Biosciences Ab filed Critical Amersham Biosciences Ab
Priority to SE0400501A priority Critical patent/SE0400501D0/sv
Publication of SE0400501D0 publication Critical patent/SE0400501D0/sv
Priority to DE602005016220T priority patent/DE602005016220D1/de
Priority to JP2007500724A priority patent/JP4776615B2/ja
Priority to NZ548127A priority patent/NZ548127A/en
Priority to EP05722174A priority patent/EP1718668B1/en
Priority to PCT/SE2005/000292 priority patent/WO2005082926A1/en
Priority to KR1020067017115A priority patent/KR101149969B1/ko
Priority to AT05722174T priority patent/ATE440858T1/de
Priority to CA2552823A priority patent/CA2552823C/en
Priority to AU2005217348A priority patent/AU2005217348B2/en
Priority to US10/589,718 priority patent/US7385040B2/en
Priority to CN2005800062670A priority patent/CN1926146B/zh
Priority to PCT/SE2005/000293 priority patent/WO2005082483A1/en
Priority to NZ548126A priority patent/NZ548126A/en
Priority to KR1020067017113A priority patent/KR101150050B1/ko
Priority to JP2007500725A priority patent/JP4848356B2/ja
Priority to CN200580006276XA priority patent/CN1925898B/zh
Priority to EP05722175A priority patent/EP1718386A1/en
Priority to AU2005216847A priority patent/AU2005216847B2/en
Priority to US10/589,717 priority patent/US7750129B2/en
Priority to CA2552639A priority patent/CA2552639C/en
Priority to IL176635A priority patent/IL176635A/en
Priority to IL176745A priority patent/IL176745A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/18—Ion-exchange chromatography
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/38—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving specific interaction not covered by one or more of groups B01D15/265 and B01D15/30 - B01D15/36, e.g. affinity, ligand exchange or chiral chromatography
    • B01D15/3804—Affinity chromatography
    • B01D15/3809—Affinity chromatography of the antigen-antibody type, e.g. protein A, G or L chromatography
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/38—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving specific interaction not covered by one or more of groups B01D15/265 and B01D15/30 - B01D15/36, e.g. affinity, ligand exchange or chiral chromatography
    • B01D15/3847—Multimodal interactions
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J39/00—Cation exchange; Use of material as cation exchangers; Treatment of material for improving the cation exchange properties
    • B01J39/04—Processes using organic exchangers
    • B01J39/07—Processes using organic exchangers in the weakly acidic form
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J39/00—Cation exchange; Use of material as cation exchangers; Treatment of material for improving the cation exchange properties
    • B01J39/26—Cation exchangers for chromatographic processes
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J47/00—Ion-exchange processes in general; Apparatus therefor
    • B01J47/014—Ion-exchange processes in general; Apparatus therefor in which the adsorbent properties of the ion-exchanger are involved, e.g. recovery of proteins or other high-molecular compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/165—Extraction; Separation; Purification by chromatography mixed-mode chromatography
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/36—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving ionic interaction, e.g. ion-exchange, ion-pair, ion-suppression or ion-exclusion
    • B01D15/361—Ion-exchange
    • B01D15/362—Cation-exchange

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
SE0400501A 2004-02-27 2004-02-27 Antibody purification SE0400501D0 (sv)

Priority Applications (23)

Application Number Priority Date Filing Date Title
SE0400501A SE0400501D0 (sv) 2004-02-27 2004-02-27 Antibody purification
CN2005800062670A CN1926146B (zh) 2004-02-27 2005-02-24 抗体纯化
US10/589,718 US7385040B2 (en) 2004-02-27 2005-02-24 Antibody purification
JP2007500724A JP4776615B2 (ja) 2004-02-27 2005-02-24 抗体精製
NZ548127A NZ548127A (en) 2004-02-27 2005-02-24 Method for antibody purification
EP05722174A EP1718668B1 (en) 2004-02-27 2005-02-24 Antibody purification
PCT/SE2005/000292 WO2005082926A1 (en) 2004-02-27 2005-02-24 Antibody purification
KR1020067017115A KR101149969B1 (ko) 2004-02-27 2005-02-24 항체 정제
AT05722174T ATE440858T1 (de) 2004-02-27 2005-02-24 Aufreinigung von antikírpern
CA2552823A CA2552823C (en) 2004-02-27 2005-02-24 Antibody purification
AU2005217348A AU2005217348B2 (en) 2004-02-27 2005-02-24 Antibody purification
DE602005016220T DE602005016220D1 (de) 2004-02-27 2005-02-24 Aufreinigung von antikörpern
CA2552639A CA2552639C (en) 2004-02-27 2005-02-25 A process for the purification of antibodies
PCT/SE2005/000293 WO2005082483A1 (en) 2004-02-27 2005-02-25 A process for the purification of antibodies
NZ548126A NZ548126A (en) 2004-02-27 2005-02-25 A process for the purification of antibodies involving addition of a second resin
KR1020067017113A KR101150050B1 (ko) 2004-02-27 2005-02-25 항체 정제 방법
JP2007500725A JP4848356B2 (ja) 2004-02-27 2005-02-25 抗体精製法
CN200580006276XA CN1925898B (zh) 2004-02-27 2005-02-25 纯化抗体的工艺
EP05722175A EP1718386A1 (en) 2004-02-27 2005-02-25 A process for the purification of antibodies
AU2005216847A AU2005216847B2 (en) 2004-02-27 2005-02-25 A process for the purification of antibodies
US10/589,717 US7750129B2 (en) 2004-02-27 2005-02-25 Process for the purification of antibodies
IL176635A IL176635A (en) 2004-02-27 2006-06-29 Method of purification of antibodies from one or more contaminants by chromatography and a system for such purification
IL176745A IL176745A (en) 2004-02-27 2006-07-06 Process for the purification of antibodies

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0400501A SE0400501D0 (sv) 2004-02-27 2004-02-27 Antibody purification

Publications (1)

Publication Number Publication Date
SE0400501D0 true SE0400501D0 (sv) 2004-02-27

Family

ID=32067281

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0400501A SE0400501D0 (sv) 2004-02-27 2004-02-27 Antibody purification

Country Status (13)

Country Link
US (1) US7385040B2 (sv)
EP (1) EP1718668B1 (sv)
JP (1) JP4776615B2 (sv)
KR (1) KR101149969B1 (sv)
CN (2) CN1926146B (sv)
AT (1) ATE440858T1 (sv)
AU (1) AU2005217348B2 (sv)
CA (1) CA2552823C (sv)
DE (1) DE602005016220D1 (sv)
IL (1) IL176635A (sv)
NZ (1) NZ548127A (sv)
SE (1) SE0400501D0 (sv)
WO (1) WO2005082926A1 (sv)

Families Citing this family (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20160279239A1 (en) 2011-05-02 2016-09-29 Immunomedics, Inc. Subcutaneous administration of anti-cd74 antibody for systemic lupus erythematosus and autoimmune disease
US20160355591A1 (en) 2011-05-02 2016-12-08 Immunomedics, Inc. Subcutaneous anti-hla-dr monoclonal antibody for treatment of hematologic malignancies
US7589183B2 (en) * 2006-11-28 2009-09-15 Bio-Rad Laboratories, Inc. Prevention of leaching of ligands from affinity-based purification systems
US7691980B2 (en) * 2007-01-09 2010-04-06 Bio-Rad Laboratories, Inc. Enhanced capacity and purification of antibodies by mixed mode chromatography in the presence of aqueous-soluble nonionic organic polymers
US7999085B2 (en) * 2007-01-09 2011-08-16 Bio-Rad Laboratories, Inc. Enhanced capacity and purification of protein by mixed mode chromatography in the presence of aqueous-soluble nonionic organic polymers
WO2008085116A1 (en) * 2007-01-10 2008-07-17 Ge Healthcare Bio-Sciences Ab Mult i -modal ion exchange chromotography resins
JP5888481B2 (ja) 2007-03-28 2016-03-22 ディーピーエックス ホールディングス ビー．ブイ． 膨張床カラムおよび使い捨て可能なクロマトグラフィー
RU2009148891A (ru) * 2007-06-01 2011-07-20 Ф.Хоффманн-Ля Рош Аг (Ch) Очистка иммуноглобулина
US9433922B2 (en) * 2007-08-14 2016-09-06 Emd Millipore Corporation Media for membrane ion exchange chromatography based on polymeric primary amines, sorption device containing that media, and chromatography scheme and purification method using the same
EP2027875A1 (en) * 2007-08-23 2009-02-25 Octapharma AG A Process for Isolation and Purification of a Target Protein free of Prion Protein (PrPSC)
AU2008315124B2 (en) * 2007-10-26 2012-06-21 Asahi Kasei Chemicals Corporation Method for purifying protein
US8158405B2 (en) * 2008-06-30 2012-04-17 General Electric Company Process for concentrating and processing fluid samples
US8546127B2 (en) * 2008-06-30 2013-10-01 General Electric Company Bacteria/RNA extraction device
US8753868B2 (en) 2008-08-04 2014-06-17 General Electric Company Method and system for selective isolation of target biological molecules in a general purpose system
US20100051554A1 (en) * 2008-08-28 2010-03-04 Dong June Ahn Molecular basket coated micro particles
WO2010071208A1 (ja) * 2008-12-19 2010-06-24 武田薬品工業株式会社 抗体の精製方法
CN101797493B (zh) * 2009-02-06 2014-05-21 上海抗体药物国家工程研究中心有限公司 一种在反应釜中制备亲和层析介质的方法
DE102009057993A1 (de) 2009-06-13 2011-01-20 Sartorius Stedim Biotech Gmbh Polysaccharidmatrix mit aufgepfropftem Polymer, Verfahren zu ihrer Herstellung und Verwendung
JPWO2011001963A1 (ja) * 2009-07-03 2012-12-13 旭化成ケミカルズ株式会社 多孔質基材に固定されたグラフト鎖に結合しているアミノ基及びアルキル基を有する多孔膜を用いた抗体の精製方法
WO2011049798A1 (en) * 2009-10-20 2011-04-28 Merck Sharp & Dohme Corp. Use of mixed mode chromatography for the capture and purification of basic antibody products
US8277649B2 (en) * 2009-12-14 2012-10-02 General Electric Company Membranes and associated methods for purification of antibodies
WO2011090719A2 (en) * 2009-12-29 2011-07-28 Dr. Reddy's Laboratories Ltd. Protein purification by ion exchange
KR101152036B1 (ko) 2010-04-27 2012-06-08 (주)셀트리온 컬럼 순환 및 시료 연속주입법을 이용한 단백질 ａ 크로마토그래피 정제 방법
WO2012015908A2 (en) 2010-07-30 2012-02-02 Millipore Corporation Chromatography media and method
AU2012250924B2 (en) 2011-05-02 2017-05-25 Immunomedics, Inc. Ultrafiltration concentration of allotype selected antibodies for small-volume administration
JP6292718B2 (ja) 2011-07-01 2018-03-14 エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ 凝集ポリペプチドから単量体ポリペプチドを分離するための方法
EP2771358A4 (en) * 2011-10-26 2015-08-26 Bio Rad Laboratories ELIMINATION OF VIRAL AGENTS IN MIXED MODE CHROMATOGRAPHY
GB201202762D0 (en) 2012-02-17 2012-04-04 Autology Health Ltd High efficiency cell capture
CN103506079B (zh) * 2012-06-19 2016-04-06 汪志友 一种用于分离纯化抗体的介质及其制备方法
SG11201501597VA (en) * 2012-09-03 2015-04-29 Kaneka Corp Mix-mode antibody affinity separation matrix and purification method using same, and target molecule
MY178616A (en) 2012-09-17 2020-10-19 Grace W R & Co Chromatography media and devices
CN104797332B (zh) 2012-11-13 2018-05-29 通用电气医疗集团生物工艺研发股份公司 多元阴离子交换基质
JP6639236B2 (ja) 2013-02-26 2020-02-05 ナトリックス セパレイションズ インコーポレーテッド 混合モードクロマトグラフィー膜
TWI596107B (zh) 2013-06-25 2017-08-21 卡地拉保健有限公司 單株抗體之新穎純化方法
KR20160054597A (ko) * 2013-09-17 2016-05-16 가부시키가이샤 가네카 신규 항체 정제 방법 및 그로부터 얻어지는 항체, 및 양이온 교환기를 사용한 신규 항체 정제법 및 그로부터 얻어지는 항체
CN105793301A (zh) * 2013-11-17 2016-07-20 纽波庭塔克有限公司 制备层析材料的方法
JP6853670B2 (ja) 2014-01-16 2021-04-07 ダブリュー・アール・グレース・アンド・カンパニー−コーンＷ Ｒ Ｇｒａｃｅ ＆ Ｃｏ−Ｃｏｎｎ 親和性クロマトグラフィー媒体及びクロマトグラフィーデバイス
RU2688349C2 (ru) 2014-03-21 2019-05-21 Ф. Хоффманн-Ля Рош Аг In vitro прогнозирование времени полужизни антител in vivo
JP6914189B2 (ja) 2014-05-02 2021-08-04 ダブリュー・アール・グレース・アンド・カンパニー−コーンＷ Ｒ Ｇｒａｃｅ ＆ Ｃｏ−Ｃｏｎｎ 官能化担体材料並びに官能化担体材料を作製及び使用する方法
DE102014010353B4 (de) 2014-07-10 2024-09-12 Sartorius Stedim Biotech Gmbh Vorrichtung, Verwendung dieser Vorrichtung und Verfahren für die Stofftrennung mit verbesserter Ausnutzung der Kapazität chromatographischer Medien
EP3173783B1 (en) 2014-07-25 2019-02-27 Asahi Kasei Medical Co., Ltd. Cation-exchange chromatography support and method for using same
AR102198A1 (es) 2014-10-09 2017-02-08 Regeneron Pharma Proceso para reducir partículas subvisibles en una formulación farmacéutica
PT3215528T (pt) 2014-11-06 2019-10-11 Hoffmann La Roche Variantes da região fc com ligação modificada ao fcrn e métodos de utilização
US20170298091A1 (en) 2014-12-08 2017-10-19 Emd Millipore Corporation Mixed Bed Ion Exchange Adsorber
CN107921407B (zh) 2015-06-05 2022-07-05 格雷斯公司 生物处理吸附澄清剂及其制备和使用方法
JP2019070528A (ja) * 2016-02-26 2019-05-09 Jsr株式会社 多孔質担体、アフィニティクロマトグラフィー用多孔質担体、標的物の精製方法、及び抗体
JP6846434B2 (ja) 2016-04-29 2021-03-24 クレオプティクス・アーゲーＣｒｅｏｐｔｉｘ Ａｇ 分子を回収するための方法およびアセンブリ
AU2017312785B2 (en) 2016-08-16 2024-10-10 Regeneron Pharmaceuticals, Inc. Methods for quantitating individual antibodies from a mixture
KR102759512B1 (ko) 2016-10-25 2025-02-03 리제너론 파아마슈티컬스, 인크. 크로마토그래피 데이터 분석을 위한 방법 및 시스템
CA3044082A1 (en) 2017-04-03 2018-10-11 Immunomedics, Inc. Subcutaneous administration of antibody-drug conjugates for cancer therapy
WO2019060062A1 (en) 2017-09-19 2019-03-28 Regeneron Pharmaceuticals Inc. METHODS OF REDUCING PARTICLE FORMATION AND COMPOSITIONS FORMED THEREFROM
CN111818980B (zh) * 2018-03-08 2022-10-11 生物辐射实验室股份有限公司 阴离子交换-疏水混合模式色谱树脂
US11155575B2 (en) 2018-03-21 2021-10-26 Waters Technologies Corporation Non-antibody high-affinity-based sample preparation, sorbent, devices and methods
WO2020004583A1 (ja) * 2018-06-29 2020-01-02 三菱ケミカル株式会社 ポリペプチドの分離方法、ポリペプチドの製造方法及びポリペプチドの精製装置
TWI919355B (zh) 2018-07-02 2026-03-21 美商里珍納龍藥品有限公司 自混合物製備多肽之系統及方法
EA202192422A1 (ru) 2019-03-05 2021-12-09 Ридженерон Фармасьютикалз, Инк. Человеческий сывороточный альбумин в составах
CN114040815B (zh) 2019-09-05 2024-06-28 生物辐射实验室股份有限公司 阴离子交换-疏水混合模式色谱树脂

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE462046C (sv) 1982-08-23 1998-04-27 Pharmacia Biotech Ab Hybrid-DNA-vektor innehållande DNA-sekvens från Staphylococcus aureus, förfarande för dess framställning och bakterie innehållande densamma
US5151350A (en) 1982-10-27 1992-09-29 Repligen Corporation Cloned genes encoding recombinant protein a
US4983722A (en) 1988-06-08 1991-01-08 Miles Inc. Removal of protein A from antibody preparations
US5429746A (en) 1994-02-22 1995-07-04 Smith Kline Beecham Corporation Antibody purification
GB9519197D0 (en) * 1995-09-20 1995-11-22 Affinity Chromatography Ltd Novel affinity ligands and their use
US6117996A (en) * 1995-09-20 2000-09-12 Novo Nordisk A/S Triazine based ligands and use thereof
EP1386660B1 (en) * 1996-08-30 2009-09-02 Upfront Chromatography A/S Isolation of immunoglobulins
SE0002688D0 (sv) 2000-07-17 2000-07-17 Amersham Pharm Biotech Ab Adsorption method and ligands
US6852230B2 (en) * 2000-12-31 2005-02-08 Amersham Biosciences Ab Method for the manufacture of compositions containing low concentrations of salts
JP2004517310A (ja) * 2001-01-05 2004-06-10 プロ・ケム インク 精製器具及び方法
SE0103084D0 (sv) 2001-09-14 2001-09-14 Amersham Pharm Biotech Ab Generation of ion exchange media
DE10155984A1 (de) 2001-11-15 2003-05-28 Boehringer Ingelheim Pharma Verfahren zur Reduktion des Liganden-leakage von Affinitätschromatographie-Matrices
EP1472275B1 (en) 2002-02-05 2008-12-17 Genentech, Inc. Protein purification
WO2004076485A1 (en) 2003-02-28 2004-09-10 Lonza Biologics Plc. Antibody purification by protein a and ion exchange chromatography

Also Published As

Publication number Publication date
US20070112178A1 (en) 2007-05-17
AU2005217348B2 (en) 2011-03-31
IL176635A (en) 2011-07-31
KR20070001969A (ko) 2007-01-04
CA2552823A1 (en) 2005-09-09
NZ548127A (en) 2009-09-25
JP2008505851A (ja) 2008-02-28
IL176635A0 (en) 2006-10-31
KR101149969B1 (ko) 2012-07-05
CN1925898A (zh) 2007-03-07
JP4776615B2 (ja) 2011-09-21
AU2005217348A1 (en) 2005-09-09
WO2005082926A1 (en) 2005-09-09
CA2552823C (en) 2013-11-19
DE602005016220D1 (de) 2009-10-08
EP1718668B1 (en) 2009-08-26
CN1926146B (zh) 2010-06-16
CN1926146A (zh) 2007-03-07
CN1925898B (zh) 2010-09-01
EP1718668A1 (en) 2006-11-08
ATE440858T1 (de) 2009-09-15
US7385040B2 (en) 2008-06-10

Similar Documents

Publication Publication Date Title
ATE440858T1 (de) Aufreinigung von antikírpern
WO2006138737A8 (en) Methods of purifying anti a beta antibodies
EA200970230A1 (ru) СПОСОБ ОЧИСТКИ Fc-СЛИТЫХ БЕЛКОВ
ATE384742T1 (de) Verfahren zur reinigung von preproinsulin
ATE425989T1 (de) Proteinreinigungsverfahren
WO2004024866A3 (en) Protein purification
EA200702210A1 (ru) Способ очистки белков
Zachariou et al. Application of immobilized metal ion chelate complexes as pseudocation exchange adsorbents for protein separation
DE60325334D1 (de) Proteinaufreinigung
DE60229051D1 (de) Humanisierte antikörper
DE602004006157D1 (de) Verfahren zur aufreinigung von il-18-bindendem protein
WO2002083710A3 (en) Removal of bacterial endotoxin in a protein solution by immobilized metal affinity chromatography
WO2007075283A3 (en) Polishing steps used in multi-step protein purification processes
DK1888636T3 (da) Fremgangsmåde til oprensning af antistoffer
Kish et al. Peptide-based affinity adsorbents with high binding capacity for the purification of monoclonal antibodies
SE0300791D0 (sv) Use of ph-responsive polymers
FR2892820B1 (fr) Procede magnetique d'immunodiagnostic pour la mise en evidence de complexe anticorps/antigene, en particulier de groupe sanguin
ATE417056T1 (de) Verfahren zur proteinreinigung
ATE328007T1 (de) Reinigung von fibrinogen aus flüssigkeiten mittels ausfällung und hydrophobischer- interaktion-chromatographie
JP2008503754A5 (sv)
WO2005026323A3 (en) Stationary phases and a purification process using the stationary phases
Savane et al. Molecular insight in the purification of immunoglobulin by pseudobiospecific ligand l-histidine and histidyl moieties in histidine ligand affinity chromatography (HLAC) by molecular docking
ATE499384T1 (de) Multimere fc-rezeptor-polypeptide
HK1213795A1 (zh) 使用疏水作用層析法進行蛋白質的提純
Gallant Immunoaffinity chromatography of proteins